Company intelligence / Profile preview

SpinalMotion

Mountain View, California, United Statesspinalmotion.guru ↗

Ownership: Private
Development stage: Commercial

Overview

SpinalMotion develops advanced artificial spinal discs using its proprietary Kineflex technology. The company has completed major clinical studies for both cervical and lumbar total disc replacement devices targeting degenerative disc disease. Its products have received CE Mark approval in Europe, while U.S. regulatory review was ongoing as of the last available reports. Clinical data presented to the FDA panel included long-term safety and efficacy results from multi-site IDE trials.

Therapeutic areas: Neurology
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Kineflex Lumbar Disc

Commercial

Indications: Degenerative disc disease

Beyond the preview

Go deeper on SpinalMotion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpinalMotion.

Explore the full profile